---
created: 2025-04-13
updated: 2025-04-13T10:52
id: b-0Jbnq?%Q
specialty: pharmaco
specialty_id: 141
tags:
  - source/ak-original-decks::step-1::zanki-pharmacology
  - "source/ak-step1-v11:": 
  - theme/firstaid::05-pharmacology::02-autonomic-drugs::10-sympathomimetics::direct
  - "source/ak-step1-v11:": 
  - theme/firstaid::05-pharmacology::02-autonomic-drugs::10-sympathomimetics::direct::phenylephrine
  - "source/ak-step1-v11:": 
  - theme/firstaid::05-pharmacology::02-autonomic-drugs::12-sympatholytics-(a2-agonists)::phenylephrine
  - "source/ak-step1-v11:": 
  - theme/firstaid::16-respiratory::05-pharm::05-pseudoephedrine-phenylephrine
  - "source/ak-step1-v11:": 
  - source/ome-banner
  - "source/ak-step1-v11:": 
  - theme/physeo::09-pharm::08-respiratory::04-pseudoephedrine,-phenylephrine
  - "source/ak-step1-v11:": 
  - theme/sketchypharm::01-autonomic-drugs::02-sympathetic::01-sympathomimetics
  - "source/ak-step1-v11:": 
  - theme/uworld::1000-9999::6000-6999::6811
  - "source/ak-step1-v11:": 
  - theme/uworld::10000-99999::18000-18999::18618
  - source/ak-step1-v11::^other::^highyield::1-highyield"
type: flashcard
---

# Question
Phenylephrine may be used to treat **hypo**-tension    * Bonus: what are the intracellular changes following IV infusion?

---

# Answer
Î±1-mediated vasoconstriction increases MAP = increases BP